Chinese Brain Implant: First Clinical Trial for Amputees
A groundbreaking clinical trial in China is testing a brain implant, enabling an amputee to control a computer cursor and perform tasks with near-normal skill. Teh device, implanted in March, successfully translates brain signals into actions, allowing the man to play chess and video games. This pioneering technology shows amazing promise.The brain implant’s role goes beyond mere control; it represents a potential leap in restoring function. The research team plans further trials for paralysis and ALS patients, setting the stage for transformative advancements in technology. News Directory 3 is following this story closely.A larger trial is scheduled for 2026, with the hope of changing lives. Discover what’s next as researchers refine this potentially life-altering brain implant.
Brain Implant Restores Function After Amputation
Updated June 14, 2025
A 37-year-old man who lost all four limbs in a high-voltage electrical accident over a decade ago is participating in a trial involving a brain implant. Researchers hope the brain implant will restore lost function.
In March, scientists implanted a coin-sized device with electrodes into the man’s brain. Within weeks, the man demonstrated the ability to manipulate a cursor on a screen. This allowed him to engage in activities such as playing chess and video games, and also performing other computer tasks with near-normal skill. The role of the implant is to translate brain signals into actions.
The research team, comprised of the Chinese Academy of Sciences’ Center for Excellence in Brain Science and Intelligence Technology, Huashan Hospital affiliated with Fudan University in Shanghai, and industry partners, plans further trials.These include small-scale studies on individuals with paralysis or amyotrophic lateral sclerosis (ALS) this year. A larger trial involving up to 40 patients is slated for 2026. This technology could change lives.
What’s next
Researchers will continue to monitor the participant’s progress and refine the brain-computer interface technology. The upcoming trials will focus on expanding the technology’s application to a wider range of neurological conditions.